omega-n-methylarginine has been researched along with tiletamine hydrochloride in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (tiletamine hydrochloride) | Trials (tiletamine hydrochloride) | Recent Studies (post-2010) (tiletamine hydrochloride) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 2,819 | 12 | 1,228 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Nucci, G; Mitchell, JA; Vane, JR; Warner, TD | 1 |
1 other study(ies) available for omega-n-methylarginine and tiletamine hydrochloride
| Article | Year |
|---|---|
Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
Topics: Animals; Arginine; Buffers; Cattle; Cells, Cultured; Cyclohexanones; Endothelium, Vascular; Epoprostenol; Hydrogen-Ion Concentration; Lipoprotein Lipase; Nitric Oxide; omega-N-Methylarginine; Platelet Activating Factor; Pyrimidinones; Thiazoles | 1991 |